home / stock / femy / femy news

FEMY News and Press, Femasys Inc.

Stock Information
Company Name: Femasys Inc.
Stock Symbol: FEMY
Market: NASDAQ
Website: femasys.com
Menu
Get FEMY Alerts

News, Short Squeeze, Breakout and More Instantly...
FEMY - Femasys regains Nasdaq listing compliance; shifts focus on growth strategy

2026-06-24 09:56:31 ET More on Femasys Seeking Alpha’s Quant Rating on Femasys Historical earnings data for Femasys Financial information for Femasys Read the full article on Seeking Alpha For further details see: Femasys regains Nasdaq lis...
FEMY - Femasys Regains Compliance with Nasdaq Listing Requirements

ATLANTA, June 24, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective for women worldwide, announced today that it received formal notice from The Nasdaq Stoc...

FEMY - Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG(TM) Catheter

ATLANTA, May 13, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective for women worldwide, announced today CE Mark approval for its FemHSG ™ Catheter, ...

FEMY - Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update

ATLANTA, May 08, 2026 (GLOBE NEWSWIRE) --   Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to women worldwide, announces its financial results for the quarter ended March 31, 2026 and...
FEMY - Femasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed® Complete

-- Integrated sperm preparation and intratubal insemination drive earlier intervention and streamlined, in-office care within routine OB/GYN practice -- ATLANTA, May 05, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator focused on making fertility and non-s...

FEMY - Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026

ATLANTA, April 22, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective for women worldwide, announced today the commercial launch of FemaSeed Complete, a comp...

FEMY - Femasys Drives International Growth with Israeli Market Entry for Fertility Portfolio

-- Partnership with AMI Technologies Positions FemaSeed ® as a First-Line Infertility Treatment in Israel, Expanding Market Access to Innovative Fertility Solutions --  ATLANTA, April 16, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator focu...
FEMY - Femasys appoints John Canning as COO

2026-04-01 09:37:33 ET More on Femasys Femasys secures Nasdaq extension to regain bid price compliance Seeking Alpha’s Quant Rating on Femasys Historical earnings data for Femasys Financial information for Femasys Read the full article on See...

FEMY - Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth

ATLANTA, April 01, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective for women worldwide, announced today the appointment of John Canning as Chief Operating...

FEMY - Femasys GAAP EPS of -$0.47, revenue of $2.29M

2026-03-31 16:54:31 ET More on Femasys Femasys secures Nasdaq extension to regain bid price compliance Seeking Alpha’s Quant Rating on Femasys Historical earnings data for Femasys Financial information for Femasys Read the full article on See...
Next 10